Simplex Trading’s Orphazyme A/S ORPH Stock Holding History

Simplex Trading’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,800	Closed	-$4K	–	11739
2022 Q1	$4K	Sell	5,800 -18,700	-76%	-$31.2K	﹤0.01%	9642
2021 Q4	$59K	Sell	24,500 -37,100	-60%	-$131K	﹤0.01%	7049
2021 Q3	$457K	Buy	61,600 +10,400	+20%	+$53.5K	﹤0.01%	4233
2021 Q2	$376K	Buy	+51,200	New	+$413K	﹤0.01%	4606

Simplex Trading's ORPH Position: Q2 2022 in Review

Simplex Trading sold out of Orphazyme A/S (ORPH) in Q2 2022, closing a stake of 3,484 shares — an estimated $2K sold.

Simplex Trading first reported a position in ORPH in Q2 2021 and held it in 4 quarters. The position peaked at $510K in Q3 2021. 1 fund tracked by Wall St. Rank holds ORPH as of Q2 2022.

Simplex Trading reported no remaining Orphazyme A/S position as of Q2 2022 after selling out during the quarter.
Simplex Trading sold 3,484 Orphazyme A/S shares in Q2 2022, an estimated $2K.
Simplex Trading first reported a position in Orphazyme A/S in Q2 2021 and held it in 4 quarters.
Simplex Trading's Orphazyme A/S position peaked at $510K in Q3 2021.
1 fund tracked by Wall St. Rank held Orphazyme A/S as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.